Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

5.81
+0.18003.20%
Volume:28.07K
Turnover:159.70K
Market Cap:123.94M
PE:-1.17
High:5.82
Open:5.63
Low:5.53
Close:5.63
Loading ...

Enanta announces ‘positive’ results from Phase 2 study of zelicapavir

TIPRANKS
·
09 Dec 2024

Enanta Pharmaceuticals Sees Positive Topline Results for RSV Drug Trials

Dow Jones
·
09 Dec 2024

BRIEF-Enanta Pharmaceuticals Announces Positive Phase 2 Results Evaluating Zelicapavir

Reuters
·
09 Dec 2024

Enanta Pharmaceuticals Announces Positive Topline Results From First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (Rsv)

THOMSON REUTERS
·
09 Dec 2024

Enanta Pharmaceuticals Inc - Antiviral Effect Observed With 1.4 Log Viral Load Decline in Part 2

THOMSON REUTERS
·
09 Dec 2024

Enanta Pharmaceuticals Inc - Zelicapavir Well-Tolerated With Favorable Safety Profile

THOMSON REUTERS
·
09 Dec 2024

Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)

Business Wire
·
09 Dec 2024

Enanta Pharmaceuticals to Present Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for Respiratory Syncytial Virus (RSV)

Business Wire
·
07 Dec 2024

Enanta Pharmaceuticals (ENTA) Receives a Sell from J.P. Morgan

TIPRANKS
·
28 Nov 2024

Enanta Pharmaceuticals’ Reduced Reporting: Potential Impact on Investor Appeal and Stock Volatility

TIPRANKS
·
28 Nov 2024

Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $14 From $16, Maintains Perform Rating

MT Newswires Live
·
27 Nov 2024

Enanta Pharmaceuticals Inc. : Oppenheimer Cuts Target Price to $14 From $16

THOMSON REUTERS
·
27 Nov 2024

Enanta Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $10 From $12

THOMSON REUTERS
·
27 Nov 2024

Enanta Pharmaceuticals Shares Fall 5% After Q4 Results

THOMSON REUTERS
·
26 Nov 2024

Enanta Pharmaceuticals Price Target Cut to $21.00/Share From $22.00 by JMP Securities

Dow Jones
·
26 Nov 2024

Enanta price target lowered to $20 from $26 at Baird

TIPRANKS
·
26 Nov 2024

U.S. RESEARCH ROUNDUP-Allstate, Mongodb, Primerica

Reuters
·
26 Nov 2024

Enanta Pharmaceuticals: Promising RSV Developments and Strong Immunology Pipeline Justify Buy Rating

TIPRANKS
·
26 Nov 2024

Enanta Pharmaceuticals Reports Q4 2024 Financials

TIPRANKS
·
26 Nov 2024

Enanta Pharmaceuticals Inc : Baird Cuts Target Price to $20 From $26

THOMSON REUTERS
·
26 Nov 2024